FIELD: pharmacology.
SUBSTANCE: essence of the invention consists in application of magnesium-2-aminoethanesulfonate magnesium compound of the general formula 
(1), which has hepatoprotective activity, for treatment of alcoholic and medicinal hepatitis.
EFFECT: application of the compound allows to reduce acute toxicity while maintaining hepatoprotective effect strength and duration in case of drug and alcoholic hepatitis.
2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH ANTIARRHYTHMIC ACTIVITY OF VARIOUS ETIOLOGIES | 2021 |
|
RU2783944C1 |
| NEW COMPLEX OF BIOLOGICALLY ACTIVE COMPOUNDS OUT OF LARCH BARK NAMED PICNOLAR | 2003 |
|
RU2252028C2 |
| METHOD OF PRODUCING A 2,6-DIMETHYLPHENYLACETAMIDE DERIVATIVE HAVING CEREBROPROTECTIVE ACTIVITY | 2018 |
|
RU2690506C1 |
| APPLICATION OF LIDOCAINE DERIVATIVE WITH LOCAL ANESTHETIC ACTIVITY, FOR TERMINAL ANESTHESIA | 2016 |
|
RU2628811C1 |
| 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE L-GLUTAMATE, HAVING PROLONGED ANTIARRHYTHMIC ACTIVITY, PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2697717C1 |
| COMPLEX SALTS OF ACIDUM ACEXAMICUM, STIMULATING REGENERATION OF BONE TISSUE, ACCELERATING PROCESSES OF REPARATIVE OSTEOGENESIS, STIMULATING MINERALIZATION OF BONE TISSUE IN OSTEOPOROSIS | 2018 |
|
RU2668966C1 |
| DRUG PREPARATION WITH HEPATOPROTECTIVE ACTIVITY | 2015 |
|
RU2595868C1 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| 2-AMINIUM-7-(DIETHYLAMINO)-4-(4-METHOXIBENZO[D][1,3]DIOXOL-5-YL)-4H-CHROMEN-3-CARBONITRILE N-ACETYLAMINOETHANOAT HAVING ANTITUMOR ACTIVITY | 2018 |
|
RU2674987C1 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
